Array biopharma to present at the ubs global life sciences conference

Boulder, colo.--(business wire)--array biopharma inc. (nasdaq: arry) today announced that its chief executive officer, robert e. conway, will speak at the ubs global life sciences conference in new york city. the public is welcome to participate in the conference through a webcast on the array biopharma website. event: ubs global life sciences conferencepresenter: robert e. conway, chief executive officer, array biopharmadate: monday, september 19, 2011time: 10:00 a.m. eastern timelocation: the grand hyatt new york, nywebcast: www.arraybiopharma.com about array biopharma array biopharma inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. for more information on array, please go to www.arraybiopharma.com.
ARRY Ratings Summary
ARRY Quant Ranking